Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

Vaccine
K H FifeDaniel A Johnson

Abstract

Two candidate vaccines to prevent infection with human papillomavirus (HPV) Types 11 and 16 were studied in similar double-blind, placebo-controlled, dose-escalation trials. L1 virus-like particle (VLP) vaccines were made from recombinant L1 capsid protein of HPV11 or HPV16. Participants received 10, 20, 50, or 100 microg of HPV11 L1 VLPs, 10, 40, or 80 microg of HPV16 L1 VLPs, or placebo at Months 0, 2, and 6. Serum geometric mean antibody levels at Month 7 were 258, 644, 647, and 1112 milli-Merck units (mMU)/ml for the 10, 20, 50, and 100 microg doses of the HPV11 L1 VLP vaccine, respectively, and 479, 808, and 732 mMU/ml for the 10, 40, and 80 microg doses of the HPV16 L1 VLP vaccine, respectively. Antibody to HPV11 and 16 was still present at Month 36 in 96.8 and 93.5% of vaccinees, respectively. Both vaccines were well tolerated and were associated with only mild to moderate injection-site reactions.

References

May 1, 1992·The Journal of General Virology·N D ChristensenR F Rando
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R KirnbauerJ T Schiller
Aug 1, 1990·Annals of Internal Medicine·D M Eddy
Apr 1, 1985·Statistics in Medicine·O Miettinen, M Nurminen
May 15, 1980·International Journal of Cancer. Journal International Du Cancer·L Gissmann, H zur Hausen
Jul 1, 1995·Journal of Medical Virology·C GoilavA Zuckerman
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
Feb 24, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K R BeutnerK M Stone
May 4, 2002·JAMA : the Journal of the American Medical Association·Jeanne S MandelblattKeerti Shah
Nov 22, 2002·The New England Journal of Medicine·Laura A KoutskyUNKNOWN Proof of Principle Study Investigators
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group

❮ Previous
Next ❯

Citations

Sep 14, 2006·Infectious Diseases in Obstetrics and Gynecology·David Soper
Sep 23, 2006·Nature Reviews. Cancer·Richard Roden, T-C Wu
Jan 11, 2007·Clinical Medicine & Research·Michelle M Lipke
Mar 1, 2008·Biologics : Targets & Therapy·Archana MonieT-C Wu
May 15, 2007·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M Müller, L Gissmann
May 15, 2007·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·E Glastetter, A M Kaufmann
Feb 8, 2006·The Pediatric Infectious Disease Journal·Ian H FrazerLuisa L Villa
Nov 8, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S KangS Y Park
Oct 21, 2005·Advances in Therapy·Alexander K C LeungH Dele Davies
Sep 6, 2005·Current Opinion in Obstetrics & Gynecology·Jessica A Kahn, David I Bernstein
Mar 8, 2006·Current Opinion in Obstetrics & Gynecology·Edward J Mayeaux
Mar 11, 2005·Expert Review of Anticancer Therapy·James MacleanAnna-Lise Williamson
Mar 11, 2005·Expert Opinion on Emerging Drugs·Neil D Christensen
Oct 20, 2006·Expert Opinion on Biological Therapy·Engy Hanna, Gloria Bachmann
Sep 22, 2009·La Presse médicale·Christiane MouginPierre Coursaget
Jan 27, 2015·Journal of Biopharmaceutical Statistics·Walthère DewéMarc Fourneau
Feb 19, 2008·The Journal of Pediatrics·Amanda F Dempsey, Gary L Freed
Dec 18, 2007·Journal of Pediatric and Adolescent Gynecology·Gillian HaberGregory D Zimet
May 20, 2006·Reviews in Medical Virology·Margaret A Stanley
Aug 22, 2006·Gynecologic Oncology·Xavier Bosch, Diane Harper
Sep 5, 2006·Vaccine·Margaret StanleyIan Frazer
Mar 23, 2006·Gynecologic Oncology·Brian M SlomovitzDiane C Bodurka
Dec 17, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·Margaret Stanley
Dec 13, 2005·Journal of Pediatric and Adolescent Gynecology·J M RiedeselJ A Kahn
Nov 29, 2005·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Jessica A Kahn
Oct 13, 2005·Vaccine·Margaret Stanley
Aug 13, 2005·Mathematical Biosciences·Elamin H Elbasha, Alison P Galvani
Jan 2, 2003·Obstetrics and Gynecology Clinics of North America·Krishnansu Sujata Tewari, Philip John DiSaia
Oct 27, 2004·Expert Opinion on Biological Therapy·Kathrin U Jansen
Jul 20, 2006·The Annals of Pharmacotherapy·Mia R Schmiedeskamp, Denise R Kockler
Apr 7, 2005·Nature Medicine·Barry C Buckland
Sep 29, 2017·Expert Review of Vaccines·Alain Luxembourg, Erin Moeller
Jan 16, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·O B ChaudhriS R Bloom
Jun 29, 2007·Clinical and Vaccine Immunology : CVI·Alfonso García-PiñeresLigia A Pinto
Apr 25, 2012·Annual Review of Biomedical Engineering·Kim A WoodrowDavid D Lo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.